ImmunoPrecise Antibodies Ltd. filed an amended Form 6-K on December 14, 2023, to include updated financial statements and XBRL data for Q2 ended October 31, 2023, but does not reflect any new events since the last filing.
AI Assistant
IMMUNOPRECISE ANTIBODIES LTD
2024
6 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.